VYNE - VYNE Therapeutics: Rapidly Progressing In The Dermatology Market April, 07 2021 02:28 PM VYNE Therapeutics Inc Com VYNE has two approved products and a late-stage asset. The company has adequate cash after the recent offering. The company is a leader in the acne and rosacea markets. For further details see: VYNE Therapeutics: Rapidly Progressing In The Dermatology Market